Follicle-stimulating Hormone (Follicle-stimulating Hormone )
- UID
- IMP/IVD/2023/000104_7f41b0efb92f38a78b201d61843568ce_d4ebee7fd5ae8706d14baf2196c8a7ae
- Device class
- Class B
- Brand name
- CLIA
- License holder
- M/s. Peerless Biotech Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Follicle-stimulating Hormone (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Follicle-stimulating Hormone (CLIA) in human serum or plasma, which is intended as an aid to diagnosis of Pituitary endocrine function. The assay can be used for samples over the range of 0.2mIU/mL~200mIU/mL
Follicle-stimulating Hormone (Follicle-stimulating Hormone ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_7f41b0efb92f38a78b201d61843568ce_d4ebee7fd5ae8706d14baf2196c8a7ae. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.